New reliable biomarkers are needed to improve individual risk assessment for post‐
transplant infection, acute graft rejection and other immune‐related complications after solid …

Potent immunosuppressive drugs have been introduced into clinical care for solid organ
transplant recipients. It is now time to guide these drugs on an individual level to optimize …

Balancing immunosuppression to prevent rejection in solid organ transplant (SOT)
recipients remains challenging. Torque teno virus (TTV), a commensal non‐pathogenic …

The nonpathogenic and ubiquitous torque teno virus (TTV) is associated with
immunosuppression in solid organ transplant recipients. Studies in kidney transplant …

Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Solid organ transplantation (SOT) recipients receive immunosuppressive therapy to avoid
rejection of the transplanted organ. Immunosuppressive therapy increases the risk of …

Torquetenovirus (TTV), a small, single stranded anellovirus, is currently being explored as a
marker of immunocompetence in patients with immunological impairment and inflammatory …

The replication kinetics of nonpathogenic anelloviruses belonging to the Alphatorquevirus
genus (such as torque teno virus) might reflect the overall state of posttransplant …

Monitoring the human virome has been recently suggested as a promising and novel area of
research for identifying new biomarkers which would help physicians in the management of …

Torque teno viruses (TTV) are small DNA-viruses, of the genus Alphatorquevirus, whose
replication is linked to immune status. TTV load may be an indicator for efficacy of IS in lung …